291 filings
Page 4 of 15
8-K
i7t80tq d9
29 Oct 20
Genocea Provides Third Quarter 2020 Corporate Update
7:04am
8-K
mtx1ak08pjyroxtdi6t2
22 Sep 20
Genocea Announces FDA Acceptance of GEN-011 IND Application
7:36am
EFFECT
p3wf2k
31 Aug 20
Notice of effectiveness
12:15am
424B3
f2ioj2nct056hhsnay
28 Aug 20
Prospectus supplement
4:29pm
UPLOAD
3kyt 9p92p
26 Aug 20
Letter from SEC
12:00am
CORRESP
8qo9w7y6xq5x34ozq6
26 Aug 20
Correspondence with SEC
12:00am
8-K
e4mms 48jxc
5 Aug 20
Departure of Directors or Certain Officers
4:02pm
D
yl2r22kei84bm1y08cv8
3 Aug 20
$79.88M in equity / options / securities to be acquired, sold $75.51M, 18 investors
4:43pm
8-K
ey4a1e
30 Jul 20
Regulation FD Disclosure
2:10pm
8-K
el2hwr1lw8edrp5jzovc
30 Jul 20
Three of five patients achieved separate RECIST responses after GEN-009 administration
8:50am
8-K
luswecg gmh
23 Jul 20
Genocea Provides Second Quarter 2020 Corporate Update
7:06am
8-K
wm9hno6 dsg
22 Jul 20
Entry into a Material Definitive Agreement
4:52pm
8-K
cv9xxa1cgc6 cv
20 Jul 20
Genocea Biosciences Provides Clinical Update
9:23am
8-K
wyw2db 93xjej1
6 Jul 20
Regulation FD Disclosure
6:04am
8-K/A
qhpnd18 2kauz8088m3
19 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
S-8
i4y6cvnkept
2 Jun 20
Registration of securities for employees
4:12pm
8-K
8whrfhr
2 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
91rmn63xz9xxn
22 May 20
Other Events
6:06am